[Targeting the spliceosome: A new therapeutic strategy to counteract chemotherapy resistance in lung cancer?].

Rev Mal Respir

Université Grenoble Alpes, INSERM U1209, CNRS UMR5309, institut pour l'avancée des biosciences, site santé, Allée des Alpes, 38000, Grenoble, France.

Published: April 2024

Lung cancer is the first cancer-related cause of death worldwide. This is in partially due to therapeutic resistance, which occurs in around 70% of patients, especially those receiving platinum salts, the gold-standard chemotherapy. The massive deregulation of alternative transcript splicing processes observed in many cancers has led to the development of a new class of pharmacological agents aimed at inhibiting the activity of the splicing machinery (spliceosome). The molecular mechanisms by which these inhibitors act remain largely unknown, as do the benefits of using them in combination with other therapies. In this context, our work is focused on an inhibitor of the SRPK1 kinase, a major regulator of the spliceosome.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rmr.2024.02.013DOI Listing

Publication Analysis

Top Keywords

[targeting spliceosome
4
spliceosome therapeutic
4
therapeutic strategy
4
strategy counteract
4
counteract chemotherapy
4
chemotherapy resistance
4
resistance lung
4
lung cancer?]
4
cancer?] lung
4
lung cancer
4

Similar Publications

Identification of NIBAN2-Regulated RUNX2 Alternative Splicing Presents Novel Strategies for Antagonizing Osteoporosis.

Adv Sci (Weinh)

March 2025

Department of Spine Surgery and Musculoskeletal Tumor, Zhongnan Hospital of Wuhan University, No. 163 Donghu Road, Wuhan, Hubei, 430071, P. R. China.

Osteoporosis is characterized by excessive bone resorption and/or defects in bone formation. Identification of factors promoting osteoblast differentiation may provide potential targets for osteoporosis therapy. Through integral analyses of multiple datasets, NIBAN2 is found to be tightly associated with bone formation and osteoporosis.

View Article and Find Full Text PDF

[Expression of YARS1 in hepatocellular carcinoma and its prognostic effect].

Zhonghua Gan Zang Bing Za Zhi

February 2025

Department of Infectious Diseases, Peking University First Hospital, Beijing 100034, China.

To explore the expression of , the subform of protein-based tRNA synthase (), and its prognostic effect on the analysis of gene set enrichment in hepatocellular carcinoma The expressional condition of the gene in tumor tissue samples (374 cases) and adjacent tissue samples (50 cases) of hepatocellular carcinoma patients was compared and recorded by mining the Cancer Genome Atlas database. Hepatocellular carcinoma patients were divided into high expression and low expression groups according to this data. Logistic regression was used to analyze the relationship between and the clinical pathological characteristics of hepatocellular carcinoma patients.

View Article and Find Full Text PDF

Introduction: A significant proportion of women in their reproductive years are afflicted by endometriosis. And one of the major contributing factors to infertility linked to ovarian endometriosis is thought to be oocyte quality. The precise molecular mechanisms are still unknown.

View Article and Find Full Text PDF

The global dissemination of H5 avian influenza viruses represents a significant threat to both human and animal health. In this study, we conducted a genome-wide siRNA library screening against the highly pathogenic H5N1 influenza virus, leading us to the identification of 457 cellular cofactors (441 proviral factors and 16 antiviral factors) involved in the virus replication cycle. Gene Ontology term enrichment analysis revealed that the candidate gene data sets were enriched in gene categories associated with mRNA splicing via spliceosome in the biological process, integral component of membrane in the cellular component, and protein binding in the molecular function.

View Article and Find Full Text PDF

Functional inhibition of core spliceosomal machinery activates intronic premature cleavage and polyadenylation of pre-mRNAs.

Cell Rep

February 2025

Center for Stem Cell Biology and Tissue Engineering, Key Laboratory for Stem Cells and Tissue Engineering, Ministry of Education, Sun Yat-sen University, Guangzhou, China; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China; Department of Genetics and Cell Biology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China. Electronic address:

The catalytic role of U6 snRNP in pre-mRNA splicing has been well established. In this study, we utilize an antisense morpholino oligonucleotide (AMO) specifically targeting catalytic sites of U6 snRNA to achieve functional knockdown of U6 snRNP in HeLa cells. The data show a significant increase in global intronic premature cleavage and polyadenylation (PCPA) events, similar to those observed with U1 AMO treatment, as demonstrated by mRNA 3'-seq analysis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!